Article

Optical Metabolic Imaging of Heterogeneous Drug Response in Pancreatic Cancer Patient Organoids

2019-02-06

Abstract excerpt

New tools are needed to match pancreatic cancer patients with effective treatments. Patient-derived organoids offer a high-throughput platform to personalize treatments and discover novel therapies. Currently, methods to evaluate drug response in organoids are limited because they cannot be completed in a clinically relevant time frame, only evaluate response at one time point, and most importantly, overlook cellu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 006c0157-33a8-56a5-b948-2ea536f11239
DOI: 10.1101/542167

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Optical Metabolic Imaging of Heterogeneous Drug Response in Pancreatic Cancer Patient OrganoidsDOI 10.1101/542167Read

Quantitative Spatial Analysis of Metabolic Heterogeneity Across in vivo and in vitro Tumor ModelsSemantic proximity Read

The Use of Patient-Derived Organoids in the Study of Molecular Metabolic Adaptation in Breast CancerSemantic proximity Read

Integrated spatial omics of metabolic reprogramming and the tumor microenvironment in pancreatic cancerSemantic proximity Read

Pancreatic cancer patient-derived organoids capture therapy response and tumor evolutionSemantic proximity Read

Wide-Field Optical Redox Imaging with Leading-Edge Detection Enables Assessment of Treatment Response and Heterogeneity in Patient-Derived Cancer Organoids.Semantic proximity Read

Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrenceSemantic proximity Read

Wide-field optical redox imaging with leading-edge detection for assessment of patient-derived cancer organoidsSemantic proximity Read

Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinomaSemantic proximity Read

The application of organoids in treatment decision-making for digestive system cancers: progress and challengesSemantic proximity Read

An Engineered Patient‐Derived Tumor Organoid Model That Can Be Disassembled to Study Cellular Responses in a Graded 3D MicroenvironmentSemantic proximity Read

Tumor Organoids Grown in Mixed-Composition Hydrogels Recapitulate the Plasticity of Pancreatic CancersSemantic proximity Read

Drug screening at single-organoid resolution via bioprinting and interferometrySemantic proximity Read